| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus cohnii (coagulase-negative + oxacillin-susceptible) |
>0.5 |
>2 |
≤0.5 － >2 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX)  |
412 |
| Staphylococcus cohnii (coagulase-negative + oxacillin-susceptible) |
1 |
2 |
≤0.12 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
412 |
| Staphylococcus cohnii (coagulase-negative + oxacillin-susceptible) |
2 |
4 |
≤0.25 － >32 |
Ceftriaxone (Rocephin) |
412 |
| Staphylococcus cohnii (coagulase-negative + oxacillin-susceptible) |
4 |
8 |
0.25 － >16 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
412 |
| Staphylococcus cohnii (methicillin-resistant) |
0.03 |
0.25 |
<0.008 － 4 |
Sitafloxacin |
12 |
| Staphylococcus cohnii (methicillin-resistant) |
0.06 |
0.5 |
0.015 － 4 |
Clinafloxacin (PD 127391) |
12 |
| Staphylococcus cohnii (methicillin-resistant) |
0.12 |
2 |
0.03 － >16 |
Moxifloxacin (BAY 12-8039, Avelox) |
12 |
| Staphylococcus cohnii (methicillin-resistant) |
0.25 |
0.5 |
0.06 － >16 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
12 |
| Staphylococcus cohnii (methicillin-resistant) |
0.25 |
4 |
0.03 － >16 |
Gatifloxacin (Tequin) |
12 |
| Staphylococcus cohnii (methicillin-resistant) |
0.5 |
8 |
0.06 － >16 |
Levofloxacin (Levaquin, Quixin) |
12 |
| Staphylococcus cohnii (methicillin-susceptible) |
0.015 |
0.12 |
<0.008 － 1 |
Sitafloxacin |
12 |
| Staphylococcus cohnii (methicillin-susceptible) |
0.03 |
0.12 |
0.015 － 2 |
Clinafloxacin (PD 127391) |
12 |
| Staphylococcus cohnii (methicillin-susceptible) |
0.03 |
0.25 |
<0.008 － 16 |
Trovafloxacin (Trovan) |
12 |
| Staphylococcus cohnii (methicillin-susceptible) |
0.12 |
0.5 |
0.03 － 8 |
Moxifloxacin (BAY 12-8039, Avelox) |
12 |
| Staphylococcus cohnii (methicillin-susceptible) |
0.25 |
0.5 |
0.06 － >16 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
12 |
| Staphylococcus cohnii (methicillin-susceptible) |
0.5 |
8 |
0.06 － >16 |
Levofloxacin (Levaquin, Quixin) |
12 |